Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.670 | 0.710 | 0.040 |
Stocks | 99.340 | 99.340 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.304 | 20.040 |
Price to Book | 4.036 | 4.095 |
Price to Sales | 1.808 | 2.444 |
Price to Cash Flow | 17.352 | 16.416 |
Dividend Yield | 1.530 | 1.364 |
5 Years Earnings Growth | 11.032 | 12.531 |
Number of long holdings: 52
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.99 | 603.7 | -0.66% | |
AstraZeneca | GB0009895292 | 6.19 | 11,312.0 | +0.71% | |
Eli Lilly | US5324571083 | 6.10 | 809.38 | +0.66% | |
J&J | US4781601046 | 6.06 | 152.50 | +0.89% | |
Roche Holding Participation | CH0012032048 | 5.54 | 286.20 | +1.92% | |
Thermo Fisher Scientific | US8835561023 | 3.85 | 605.75 | +6.60% | |
Lonza Group | CH0013841017 | 3.74 | 593.40 | +2.49% | |
UnitedHealth | US91324P1021 | 3.70 | 540.01 | +0.36% | |
Pfizer | US7170811035 | 2.82 | 26.75 | +0.51% | |
AbbVie | US00287Y1091 | 2.70 | 175.59 | +0.19% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 124.69B | 32.75 | 15.56 | 14.46 | ||
DNB Teknologi NOK | 86.09B | 40.12 | 21.87 | 22.47 | ||
Pensjonsprofil 80 | 52.09B | 16.25 | 6.20 | 8.70 | ||
DNB Global IV | 42.8B | 28.37 | 16.18 | 14.68 | ||
Pensjonsprofil 50 | 28.73B | 11.83 | 4.42 | 6.47 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review